Bristol-Myers Squibb Company
PET-IMAGING IMMUNOMODULATORS
Last updated:
Abstract:
The invention relates to the synthesis and use of .sup.18F-labeled millamolecules for imaging various processes within the body, for detecting the location of molecules associated with disease pathology, and for monitoring disease progression are disclosed.
Status:
Application
Type:
Utility
Filling date:
26 Aug 2021
Issue date:
16 Dec 2021